Suchergebnisse - "Adamson, David Cory"

PubPharm (26)

11

OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways

enthalten in: International journal of oncology | 2015

von Li, J. | Di, C. | Jing, J. | +3

12

Radiation-induced malignant gliomas : a current review

enthalten in: World neurosurgery | 2015

von Elsamadicy, A. | Babu, R. | Kirkpatrick, J. | +1

CommentIn: World Neurosurg. 2015 Apr;83(4):457-9. - PMID 25596434

13

OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways

enthalten in: International journal of oncology | 2015

von LI, J. | DI, C. | JING, J. | +3

14

Radiation-induced malignant gliomas: a current review

enthalten in: World neurosurgery | 2015

von Elsamadicy, A. | Babu, R. | Kirkpatrick, J. | +1

15

Adherens junctional associated protein-1 : a novel 1p36 tumor suppressor candidate in gliomas (Review)

enthalten in: International journal of oncology | 2014

von Zeng, L. | Fee, B. | Rivas, M. | +2

16

AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization

enthalten in: CNS neuroscience & therapeutics | 2014

von Han, L. | Zhang, K. | Zhang, J. | +9

17

The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM

enthalten in: International journal of oncology | 2014

von Zeng, L. | Kang, C. | Di, C. | +4

18

Gliomas : classification, symptoms, treatment and prognosis

Erschienen: New York, Nova Science, [2014]

Neuroscience research progress

von Adamson, D.

19

Editorial : emerging treatment strategies for malignant gliomas

enthalten in: Current drug discovery technologies | 2012

von Adamson, D.

20

Fluorescence-guided malignant glioma resections

enthalten in: Current drug discovery technologies | 2012

von Babu, R. | Adamson, D.